Jazz Pharmaceuticals plc Subsidiaries
Every subsidiary the company listed in Exhibit 21 of its annual reports, newest list first (18 lists). Names and jurisdictions are as filed.
- 2023-03-01: Subsidiary Jazz Pharmaceuticals Ireland Limited; Jurisdiction Ireland.
- 2023-03-01: Subsidiary Jazz Financing I DAC; Jurisdiction Ireland.
- 2023-03-01: Subsidiary GW Pharma Limited; Jurisdiction United Kingdom.
- 2023-03-01: Subsidiary Jazz Pharmaceuticals, Inc.; Jurisdiction Delaware.
| Annual report filed | Subsidiary | Jurisdiction |
|---|---|---|
| 2023-03-01 | Jazz Pharmaceuticals Ireland Limited | Ireland |
| 2023-03-01 | Jazz Financing I DAC | Ireland |
| 2023-03-01 | GW Pharma Limited | United Kingdom |
| 2023-03-01 | Jazz Pharmaceuticals, Inc. | Delaware |
| 2023-03-01 | Celator Pharmaceuticals Inc. | Delaware |
| 2023-03-01 | GW Research Limited | United Kingdom |
| 2023-03-01 | Gentium S.r.l. | Italy |
| 2023-03-01 | Jazz Pharmaceuticals UK Holdings Limited | United Kingdom |
| 2023-03-01 | Jazz Securities DAC | Ireland |
| 2023-03-01 | Jazz Financing Holdings Limited | Ireland |
| 2023-03-01 | Jazz Financing Lux S.à.r.l | Luxembourg |
| 2023-03-01 | Jazz Pharmaceuticals International Limited | Bermuda |
| 2023-03-01 | Jazz Investments Europe Limited | Malta |
| 2023-03-01 | Jazz Investments I Limited | Bermuda |
| 2023-03-01 | Jazz Capital Limited | Ireland |
| 2023-03-01 | Jazz Pharmaceuticals UK Limited | United Kingdom |
| 2023-03-01 | GW Pharmaceuticals Limited | United Kingdom |
| 2023-03-01 | Cavion Inc | Delaware |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |